Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Zimmer Biomet (ZBH)

NYSE: ZBH · Health Care Equipment · Warsaw, IN

Our rating: Positive

Positive reaffirmed at $106.85, moderate conviction, November 5, 2026.

Breaks if: The Positive view breaks if free cash flow margin falls below 15% of revenue — from roughly 18% today — in any two of the next three quarterly filings, signaling that the cash-conversion story is eroding rather than holding steady under amortization load; or if year-over-year revenue growth decelerates below 4% for two consecutive quarters, implying the end-market tailwind is fading faster than demographic math alone would predict. The view would sharpen toward Conviction if FCF margin expands above 20% while revenue growth sustains above 7%, giving a materially cleaner risk-reward than the current picture offers.

Key figures

Market value$19.1B
Revenue, last 12 months$8.6B
Net income, last 12 months$767M
Free cash flow, last 12 months$1.6B
Price to earnings24.9×
Free cash flow yield8.6%
Dividend yield0.9%
Operating margin13.6%
Return on equity6.0%
Beta to the S&P 5000.34
Volatility, annualized30.1%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$2.1B3.1%$1.00$484M
June 30, 2026$2.2B4.8%$1.03$394M
March 31, 2026$2.1B9.3%$1.22$323M
December 31, 2025$2.2B10.9%$0.71$443M
September 30, 2025$2.0B9.7%$1.16$364M
June 30, 2025$2.1B7.0%$0.77$328M
March 31, 2025$1.9B1.1%$0.91$338M
December 31, 2024$2.0B4.3%$1.19$455M

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

10 ledger entries and 56 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.